Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie O Peacock

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Molecular Endocrinology (Baltimore, Md.)|October 2, 2012
Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survivalStephanie O Peacock, Cale D Fahrenholtz, Kerry L Burnstein
The Journal of Biological Chemistry|January 3, 2013
Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growthFayi Wu, Stephanie O Peacock, Shuyun Rao, et al.
Molecular Cancer Research : MCR|August 17, 2017
Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer VulnerabilitiesFiorella Magani, Stephanie O Peacock, Meghan A Rice, et al.
Molecular Systems Biology|August 16, 2018
Identification of an oncogenic network with prognostic and therapeutic value in prostate cancerFiorella Magani, Eric R Bray, Maria J Martinez, et al.
Science Translational Medicine|June 28, 2019
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancerNing Zhao, Stephanie O Peacock, Chen Hao Lo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Molecular Endocrinology (Baltimore, Md.)|October 2, 2012
Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survivalStephanie O Peacock, Cale D Fahrenholtz, Kerry L Burnstein
The Journal of Biological Chemistry|January 3, 2013
Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growthFayi Wu, Stephanie O Peacock, Shuyun Rao, et al.
Molecular Cancer Research : MCR|August 17, 2017
Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer VulnerabilitiesFiorella Magani, Stephanie O Peacock, Meghan A Rice, et al.
Molecular Systems Biology|August 16, 2018
Identification of an oncogenic network with prognostic and therapeutic value in prostate cancerFiorella Magani, Eric R Bray, Maria J Martinez, et al.
Science Translational Medicine|June 28, 2019
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancerNing Zhao, Stephanie O Peacock, Chen Hao Lo, et al.
Pageof 1